- Previous Close
14.85 - Open
14.76 - Bid 14.00 x --
- Ask 14.02 x --
- Day's Range
14.00 - 14.87 - 52 Week Range
11.01 - 21.78 - Volume
8,807,902 - Avg. Volume
7,732,550 - Market Cap (intraday)
8.237B - Beta (5Y Monthly) 0.35
- PE Ratio (TTM)
15.91 - EPS (TTM)
0.88 - Earnings Date --
- Forward Dividend & Yield 0.20 (1.43%)
- Ex-Dividend Date May 7, 2024
- 1y Target Est
23.15
Beijing Strong Biotechnologies,Inc. offers in-vitro diagnostics products and services in the People's Republic of China and internationally. The company provides clinical biochemistry products, such as reagents and automatic biochemistry analyzers; coagulation products, including reagents and automated coagulation analyzers; pathology and liquid buiopsy and serology products comprising blood type test cards and automated blood grouping analyzers. In addition, it engages in the rental of healthcare instruments; and offers inspection services. The company was founded in 2001 and is headquartered in Beijing, the People's Republic of China.
www.bsbe.com.cn--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 300406.SZ
View MorePerformance Overview: 300406.SZ
Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300406.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300406.SZ
View MoreValuation Measures
Market Cap
8.24B
Enterprise Value
8.41B
Trailing P/E
15.91
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.79
Price/Book (mrq)
2.07
Enterprise Value/Revenue
4.82
Enterprise Value/EBITDA
12.73
Financial Highlights
Profitability and Income Statement
Profit Margin
30.13%
Return on Assets (ttm)
7.67%
Return on Equity (ttm)
13.97%
Revenue (ttm)
1.75B
Net Income Avi to Common (ttm)
525.81M
Diluted EPS (ttm)
0.88
Balance Sheet and Cash Flow
Total Cash (mrq)
994.56M
Total Debt/Equity (mrq)
29.55%
Levered Free Cash Flow (ttm)
723.91M